Chemotaxis is the migration of cells in response to a gradient of attractants and is also thought to contribute to the metastasis of highly invasive cancers such as melanoma. Robert Insall's group previously reported that the phospholipid signalling molecule lysophosphatidic acid (LPA) is a strong chemoattractant for melanoma cells and establishes a self-generating gradient, with a low LPA concentration within the tumour and high LPA on the outside. On page 3455, Olivia Susanto and colleagues now build on this earlier work and investigate in more detail the mechanisms by which melanoma cells break down LPA, focusing on the role of lipid phosphate phosphatase 3 (LPP3). To that end, they first develop a robust chemotactic assay for self-generated chemotaxis. The authors then use this to show that knockdown of LPP3 reduces the ability of melanoma cells to break down LPA molecules that are chemotactically active, such as the 18:1 and 20:4 species, and leads to a delay in cell migration. This confirms that LPP3 is indeed the key enzyme for LPA degradation and that its breakdown is responsible for chemotaxis, as inhibition of de novo LPA synthesis had no effect. Furthermore, the authors also demonstrate the importance of LPA gradients for invasion in a 3D setting. Taken together, these data provide clear evidence for the role of LPA degradation in steering melanoma cells; this might also be relevant for future therapeutic strategies against invasive cancers.
LPA breakdown in melanoma invasion
LPA breakdown in melanoma invasion. J Cell Sci 15 October 2017; 130 (20): e2001. doi:
Download citation file:
Advertisement
Cited by
Call for papers: Cell Biology of Mitochondria
We are welcoming submissions for our upcoming special issue: Cell Biology of Mitochondria. This issue will be coordinated by two Guest Editors: Ana J. Garcia-Saez (University of Cologne, Germany) and Heidi McBride (McGill University, Canada). Submission deadline: 1 October 2024.
Focal adhesion kinase signalling – tumour vulnerabilities and clinical opportunities
In this Review, David Schlaepfer and colleagues summarise 30 years of focal adhesion kinase (FAK) research with a view of the ongoing clinical testing of small-molecule FAK inhibitors. The authors touch on how FAK plays an important signal integration role and ultimately functions to guide cellular behaviour. Additionally, the authors discuss how FAK inhibition might present a powerful tool to influence the physiological response to other therapeutic approaches.
JCS-FocalPlane Training Grants
Early-career researchers - working in an area covered by JCS - who would like to attend a microscopy training course, please apply. Deadline dates for 2024 applications: 7 September (decision by week commencing 8 October 2024); 22 November (decision by week commencing 16 December).
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Interview with Journal of Cell Science Editor Rob Parton
Read our interview with Rob Parton, a Cell Scientist to Watch, about his career journey leading him from the UK to the University of Queensland in Brisbane, Australia, the evolution of the membrane trafficking field and his advice for running a highly collaborative lab. As a Journal of Cell Science Editor, Rob brings to the journal his expertise in multiscale analysis of membrane function, membrane microdomains, lipid droplets and advanced microscopy techniques in cell biology.